Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …

Purpose: Although associated with an overall favorable survival rate, the heterogeneity of
non-muscle invasive bladder cancer (NMIBC) affects patients' rates of recurrence and …

Importance Robot-assisted radical cystectomy is being performed with increasing frequency,
but it is unclear whether total intracorporeal surgery improves recovery compared with open …

Background Radical cystectomy is the surgical standard for invasive bladder cancer. Robot-
assisted cystectomy has been proposed to provide similar oncological outcomes with lower …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Purpose: Radical cystectomy (RC) with urinary diversion (UD) is still considered a complex
surgery associated with significant morbidity. Open RC (ORC) remains the reference option …

Bladder cancer is the sixth most prevalent malignancy in the United States and causes more
than 16,000 deaths annually. The most common clinical presentation is asymptomatic …

Background Open radical cystectomy (ORC) has proven to be an important component in
the treatment of high-risk bladder cancer (BCa). ORC surgical morbidity remains high; …

Background Laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy
(RARC) are increasingly popular, but high-level evidence for these techniques remains …